A Phase 1b, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Single-Dose, Pharmacokinetic, Pharmacodynamic, Safety, and Tolerability Study of ASKP1240 in de Novo Kidney Transplantation.
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Bleselumab (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 22 May 2013 Results presented at the American Transplant Congress - 13th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.
- 09 Feb 2012 Actual end date (January 2012) added as reported by ClinicalTrials.gov.
- 09 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History